Economic evaluation of the use of insulin glargine compared with NPH insulin in patients with Type 2 diabetes in Spain

被引：0

作者：

Rodríguez, J

Terrés, CR

Bolinder, B

de Pablos, P

机构：

[1] HERO Consulting Hlth Econ & Res Outcomes, Madrid, Spain

[2] Aventis Pharma, Bridgewater, NJ USA

[3] Univ Las Palmas de Gran Canaria, Las Palmas Gran Canaria, Spain

来源：

DIABETOLOGIA | 2004年 / 47卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

958

引用

页码：A344 / A344

页数：1

共 50 条

[1] Economic analysis of insulin glargine compared with NPH insulin in the treatment of patients with Type 1 diabetes in Spain
Terrés, CR
Rodríguez, J
Bolinder, B
de Pablos, P
[J]. DIABETOLOGIA, 2004, 47 : A345 - A345
[2] Pharmacoeconomic analysis of insulin glargine compared with NPH insulin in patients with type 2 diabetes in Spain
Terres, CR
Rodríguez, J
Bolinder, B
De Pablos, P
[J]. DIABETES, 2004, 53 : A291 - A291
[3] Cost-utility analysis of insulin glargine compared with NPH insulin in patients with type 1 diabetes in Spain
Terrés, CR
Rodríguez, J
Bolinder, B
De Pablos, P
[J]. DIABETES, 2004, 53 : A291 - A292
[4] Insulin glargine versus NPH insulin in patients with type 1 diabetes
Ratner, R
[J]. DRUGS OF TODAY, 2003, 39 (11) : 867 - 876
[5] Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients
Pan, Chang-Yu
Sinnassamy, Patrick
Chung, Kab-Do
Kim, Kwang-Won
[J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (01) : 111 - 118
[6] Less symptomatic hypoglycemia with insulin glargine compared to NPH in patients with type 2 diabetes.
Fonseca, V
Bell, D
Mecca, T
[J]. DIABETOLOGIA, 2001, 44 : A207 - A207
[7] THE EFFECT OF GLARGINE AND NPH INSULIN IN PATIENTS WITH DIABETES MELLITUS TYPE 2
Nechevska, L.
Nechevski, M.
Nechevska, E.
Boskovski, B.
[J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
[8] Outcomes with insulin glargine in patients with type 2 diabetes previously on NPH insulin: evidence from clinical practice in Spain
Delgado, E.
[J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (03) : 281 - 288
[9] Safety and efficacy of insulin glargine compared with NPH insulin in older adults with type 2 diabetes mellitus
Lee, P. G.
Chang, A. M.
Blaum, C.
Vlajnic, A.
Miller, M. F.
Halter, J. B.
[J]. DIABETOLOGIA, 2009, 52 : S382 - S382
[10] Less symptomatic hypoglycemia with bedtime insulin glargine (Lantus®) compared to bedtime NPH insulin in patients with type 2 diabetes
Fonseca, V
Bell, D
Mecca, T
[J]. DIABETES, 2001, 50 : A112 - A112

← 1 2 3 4 5 →